Medtronic expands global access to the benefits of robotic-assisted surgery

Hugo™ robotic-assisted surgery system regulatory approval in japan provides access to third largest robotics market in the world while general surgery approval in the eu and canada open fast-growing hernia specialty dublin , oct. 19, 2022 /prnewswire/ -- medtronic plc (nyse:mdt), a global healthcare technology leader, has announced three significant global market-entrance and indication expansion approvals for its hugo™ robotic-assisted surgery (ras) system. the approvals include: conformitÉ europÉenne (ce) mark clearance for general surgery indication; health canada licence for general laparoscopic surgery indication; and ministry of health, labor, and welfare (mhlw) approval for urologic surgical and gynecologic laparoscopic indications in japan.
MDT Ratings Summary
MDT Quant Ranking